Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ablynx prices IPO

Ablynx (Euronext:ABLX) raised EUR 75 million ($108.9 million) through the sale of 10.7

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE